Why did Microsoft lay off 3% of workforce?
How will Trump’s tariffs impact U.S. inflation?
What caused American Eagle to withdraw FY25 guidance?
How does Nvidia’s Saudi AI deal affect its stock?
Why is UnitedHealth CEO stepping down abruptly?
What’s behind China-US 90-day tariff truce?
How will 3M’s $450M water contamination payout affect them?
Why are Nissan and Honda slashing jobs and profits?
What impact will the Qatar jet gift to Trump have?
These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results
benzinga.com/25/05/45386547/these-analysts-revise-their-forecasts-on-karyopharm-therapeutics-after-q1-results
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) reported mixed financial results for the first quarter on Monday.
The company posted quarterly losses of $2.77 per share which beat the analyst consensus estimate of losses of $4.16 per share. The company reported quarterly sales of $30.02…
This story appeared on benzinga.com, 2025-05-13 17:39:58.